World Mental Health Day, Oct. 10, is a day to raise awareness of mental health issues around the world and to mobilize efforts in support of mental health. Carleton experts are available to discuss related topics.
Kim Hellemans
Professor, Neuroscience
Email: Kim.Hellemans@carleton.ca
Hellemans is available to discuss young adult and university student mental health; substance use and addictions; stigma related to mental health and substance use; cannabis use and mental health; as well as social media use and mental health. She is also available to discuss the gender differences for these mental health topics.
Hellemans’ research on the factors contributing to mental health and academic challenges among students with a focus on current life stressors, cannabis use and social media.
She is a co-host of the Minding the Brain podcast.
Jim Davies
Professor, Cognitive Science
Email: Jim.Davies@carleton.ca
Davies is available to discuss stress as it relates to time management.
As director of the Science of Imagination Laboratory, Davies explores computational modelling and artificial intelligence applied to human visual imagination. His work has shown how people use visual thinking to solve problems and how they visualize imagined situations and worlds. He is a frequent contributor to Nautilus magazine and is author of Riveted: The Science of How Jokes Make Us Laugh, Movies Make Us Cry, and Religion Makes Us Feel One with the Universe. He is a co-host of the Minding the Brain podcast.
Argel Aguilar-Valles
Professor, Neuroscience
Email: Argel.AguilaValles@carleton.ca
Aguilar-Valles is available to discuss stress and its impact on mental health, as well as antidepressants and new antidepressant therapies.
Aguilar-Valles oversees the Aguilar-Valles Lab, which focuses on the molecular mechanisms that underlie psychiatric and neurodevelopmental disorders. They use a combination of biochemistry, molecular biology and animal models to understand how genetic risk factors contribute to mental illness. They are investigating how genetic mutations affect brain development and autism spectrum disorders (ASDs) pathophysiology and how antidepressant activation of the mTORC1 pathway contributes to major depressive disorder (MDD) treatment.
Media relations
Steven Reid (he/him)
Media Relations Officer
Carleton University
613-265-6613
Steven.Reid3@carleton.ca
Follow us on Twitter: www.twitter.com/Cunewsroom
COVID 19 Updates: https://newsroom.carleton.ca/coronavirus-covid-19/messages/
Thursday, October 7, 2021 in Experts Available
Share: Twitter, Facebook
